The chemical class of CLC-3 activators consists of compounds that indirectly influence the activity of the CLC-3 chloride channel. These activators function through a variety of mechanisms, primarily by modulating cellular signaling pathways and ion homeostasis, which in turn can affect the activity of ion channels including CLC-3. The key to understanding the action of these chemicals lies in their diverse impact on cellular processes and molecular targets.
For instance, compounds such as Forskolin, IBMX, and Epinephrine elevate intracellular cAMP levels, a secondary messenger known to modulate various ion channels, potentially including CLC-3. This modulation could lead to alterations in chloride transport and homeostasis, indirectly influencing CLC-3 activity. Similarly, Genistein, through its inhibition of tyrosine kinases, may impact signaling pathways that converge on ion channel regulation, thereby affecting CLC-3. Other compounds in this class, like DIDS and NPPB, are known to interact with chloride channels directly or indirectly. Their role in modulating chloride transport mechanisms provides a plausible pathway through which they could influence CLC-3 activity. Diuretics like Bumetanide, which inhibit specific ion transporters such as NKCC, may also indirectly impact CLC-3 by altering the overall chloride and ionic balance within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP levels, which can modulate various ion channels, potentially influencing CLC-3 activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific inhibitor of phosphodiesterases, increases cAMP and cGMP levels in cells, possibly affecting CLC-3 activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
A hormone and neurotransmitter that activates adrenergic receptors, leading to increased cAMP levels, which could indirectly modulate CLC-3 activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor that can influence various signaling pathways, potentially affecting CLC-3 activity. | ||||||
5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB) | 107254-86-4 | sc-201542 sc-201542B sc-201542A | 10 mg 25 mg 50 mg | $109.00 $193.00 $317.00 | 7 | |
A chloride channel blocker that might influence CLC-3 by modulating related chloride transport mechanisms. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Inhibits Na+/K+-ATPase, potentially altering ionic balance and indirectly affecting CLC-3 activity. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Known for its estrogen receptor modulation, but also affects various ion channels, potentially including CLC-3. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
A phosphodiesterase inhibitor which raises intracellular cAMP levels, possibly influencing CLC-3 activity. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker that might indirectly influence CLC-3 activity through alterations in cellular ion homeostasis. | ||||||